Literature DB >> 11907654

Impact of sepsis, lung injury, and the role of lipid infusion on circulating prostacyclin and thromboxane A(2).

U Suchner1, D P Katz, P Fürst, K Beck, T W Felbinger, M Thiel, U Senftleben, A E Goetz, K Peter.   

Abstract

OBJECTIVE: To investigate whether plasma levels of prostacyclin (PGI2) and thromboxane A(2) (TxA2) are a function of the infusion rate of soybean-based fat emulsions, severity of systemic inflammation, and pulmonary organ failure.
DESIGN: Prospective, randomized, crossover study.
SETTING: Intensive care unit of a university hospital. PATIENTS: Eighteen critically ill patients, ten presenting with severe sepsis, eight with SIRS or sepsis complicated with ARDS.
INTERVENTIONS: Patients were randomly assigned to receive rapid fat infusion over 6 h (rFI) or slow fat infusion over 24 h (sFI) along with parenteral nutrition. MEASUREMENTS AND
RESULTS: The stable prostanoids 6-keto-PGF1alpha and TxB2 were measured in arterial and mixed venous blood samples, and at 6-h periods trans-pulmonary balances (TPB) were calculated. Free linoleic acid fraction was determined in arterial blood. rFI induced greater increase of linoleic acid than sFI in both groups. Enhanced prostanoid levels and correlations with linoleic acid availabilities were found, however, in ARDS patients only, revealing the highest sepsis- and lung injury scores. Averaged TPB per 24 h was positive in the sepsis group and negative in the ARDS group as rFI induced lowest TPB values for TxB2 at 6 h.
CONCLUSION: The quantity of prostanoids formed and their subsequent utilization are dependent on the availability of precursor linoleic acid and are probably affected by the severity of SIRS or sepsis and the existence of pulmonary organ failure, respectively. Because TxA2 might be extracted by the injured lung, rapid infusion of soybean-based fat emulsions should be avoided in patients suffering from severe pulmonary organ failure.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11907654     DOI: 10.1007/s00134-001-1192-3

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  7 in total

Review 1.  Fish oil in critical illness: mechanisms and clinical applications.

Authors:  Renee D Stapleton; Julie M Martin; Konstantin Mayer
Journal:  Crit Care Clin       Date:  2010-07       Impact factor: 3.598

2.  Preparation and anesthetic properties of propofol microemulsions in rats.

Authors:  Timothy E Morey; Jerome H Modell; Dushyant Shekhawat; Todd Grand; Dinesh O Shah; Nikolaus Gravenstein; Susan P McGorray; Donn M Dennis
Journal:  Anesthesiology       Date:  2006-06       Impact factor: 7.892

3.  CRTH2 is a critical regulator of neutrophil migration and resistance to polymicrobial sepsis.

Authors:  Makoto Ishii; Koichiro Asano; Ho Namkoong; Sadatomo Tasaka; Kosuke Mizoguchi; Takahiro Asami; Hirofumi Kamata; Yoshifumi Kimizuka; Hiroshi Fujiwara; Yohei Funatsu; Shizuko Kagawa; Jun Miyata; Ken Ishii; Masataka Nakamura; Hiroyuki Hirai; Kinya Nagata; Steven L Kunkel; Naoki Hasegawa; Tomoko Betsuyaku
Journal:  J Immunol       Date:  2012-04-27       Impact factor: 5.422

Review 4.  [Lipid emulsion therapy for local anaesthetic toxicity. (LipidRescue)].

Authors:  K Ott
Journal:  Anaesthesist       Date:  2010-06       Impact factor: 1.041

Review 5.  Omega-3 fatty acids in critical illness.

Authors:  Julie M Martin; Renee D Stapleton
Journal:  Nutr Rev       Date:  2010-09       Impact factor: 7.110

6.  N-3 vs. n-6 fatty acids differentially influence calcium signalling and adhesion of inflammatory activated monocytes: impact of lipid rafts.

Authors:  Martina Barbara Schaefer; Christian Alexander Schaefer; Stefanie Schifferings; Christoph Rüdiger Wolfram Kuhlmann; Annett Urban; Utz Benscheid; Tobias Fischer; Matthias Hecker; Rory E Morty; Istvan Vadasz; Susanne Herold; Martin Witzenrath; Werner Seeger; Ali Erdogan; Konstantin Mayer
Journal:  Inflamm Res       Date:  2016-07-06       Impact factor: 4.575

Review 7.  Lipid emulsions - Guidelines on Parenteral Nutrition, Chapter 6.

Authors:  M Adolph; A R Heller; T Koch; B Koletzko; K G Kreymann; K Krohn; E Pscheidl; M Senkal
Journal:  Ger Med Sci       Date:  2009-11-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.